论文部分内容阅读
近年来酚妥拉明已广泛用于临床,在治疗小儿重症肺炎并发心力衰竭或并发腹胀及喘憋性肺炎等方面已屡见报道。作者应用酚妥拉明治疗某些临床症状较重(如气促、肺部罗音较密集)的小儿肺炎30例,结果在促进肺部罗音的吸收,改善呼吸功能方面,取得了明显疗效。现报告如下:一、一般资料1.性别及年龄治疗组30例,男18例,女12例,<1岁20例,1~2岁8例,2~3岁2例。对照组30例,男17例,女13例,<1岁23例,1~2岁4例,2~3岁3例。2.病程:入院时病程治疗组平均5天,对照组平均4.5天。3.症状与体征两组均选择有咳嗽、气促,两肺罗音密集的肺炎患儿。其中治疗组发热10例,占33.3%;发绀16例,占53.3%;烦躁不安6例,占20%;嗜睡4例,占
In recent years, phentolamine has been widely used in clinical treatment of severe pneumonia in children with heart failure or complicated with abdominal distension and asthmatic pneumonia have been frequently reported. The author applied phentolamine treatment of certain clinical symptoms of severe (such as shortness of breath, lung rashes more intensive) in children with pneumonia in 30 cases, the results in promoting pulmonary rales absorption, improve respiratory function, and achieved significant results . The report is as follows: I. General information 1. Sex and age Treatment group of 30 patients, 18 males and 12 females, <1 year old 20 cases, 1 to 2 years in 8 cases, 2 to 3 years old in 2 cases. Control group, 30 cases, 17 males and 13 females, <1 year old in 23 cases, 1 to 2 years in 4 cases, 2 to 3 years old in 3 cases. Course of disease: The course of treatment on admission was an average of 5 days in the control group, an average of 4.5 days. 3. Symptoms and signs of both groups have chosen to cough, shortness of breath, lungs intensive rales of children with pneumonia. The treatment group fever in 10 cases, accounting for 33.3%; cyanosis in 16 cases, accounting for 53.3%; restlessness in 6 cases, accounting for 20%; drowsiness in 4 cases, accounting for